The Senate health committee is floating manager's amendments, obtained by Inside Health Policy, in anticipation of Wednesday's markup of legislation to beef up FDA's oversight of drug compounding and establish a national drug tracing system. The updated compounding bill removes animal drug provisions included in an earlier draft and instead calls for a Government Accountability Office report on the issue. Stay tuned for detailed coverage of the manager's amendments.
Animal Drug Provisions Axed From Senate Compounding Bill, Replaced With GAO Report
